U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07649395) titled 'A Prospective Study of the Early Treatment of Recombinant Human Thrombopoietin for Chemoradiation Induced Thrombocytopenia in Cervical Squamous Cell Carcinoma Patient' on June 08.
Brief Summary: To explore the early intervention timing of recombinant human thrombopoietin (rhTPO) for cancer treatment-induced thrombocytopenia (CTIT) in cervical squamous cell carcinoma (CSCC) patients during concurrent chemoradiotherapy.
Study Start Date: Feb. 01, 2021
Study Type: INTERVENTIONAL
Condition:
Cervical Squamous Cell Carcinoma
Intervention:
DRUG: rhTPO
receiving rhTPO treatment when they occurred G1(100x109/L>PLT(Platelet)>75x109/L) ...